This content is restricted.
Brief
The State Drug Alert for October 2024 highlights multiple Not of Standard Quality (NSQ) and misbranded drugs, indicating serious quality and compliance failures in various pharmaceutical products. The report underscores critical issues such as dissolution failures, sterility breaches, assay inconsistencies, and labeling violations, reinforcing the need for strict regulatory oversight and adherence to quality standards.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested